Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large language model derived regular expressions for sleep phenotyping from electronic health record: a feasibility study.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Aberrant Hippocampal Neurogenesis Is a Conserved Response to Stroke in Mice: A Multicenter Multimodel Study.

Stroke·2026
Same authorSame Topic

Patient Communication Outside of Visits: Implications for Remote Monitoring and Digital Care Models in Myasthenia Gravis.

Muscle & nerve·2026
Same author

Comprehensive Care Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method.

Neurology. Clinical practice·2026
Same author

PANDA pediatric arousal neural detection architecture.

NPJ digital medicine·2026
Same author

Stroke and its consequences: protocol and pilot data of the observational Berlin Long-term Observation of Vascular Events (BeLOVE) stroke stratum.

BMJ neurology open·2026

Related Experiment Video

Updated: Jan 10, 2026

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

7.2K

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient-Reported

Maike Stein1,2,3,4, Haoqi Sun4, Sophie Lehnerer1,2,3

  • 1Department of Neurology With Experimental Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Annals of Clinical and Translational Neurology
|November 19, 2025
PubMed
Summary

Predicting myasthenia gravis (MG) crises using telemedicine data is possible. A new model using patient-reported outcomes and wearables can forecast MG deterioration, enabling earlier interventions.

Keywords:
artificial intelligencemonitoringmyasthenia gravisremote consultationsensors

More Related Videos

Evaluation of Commercial-Off-The-Shelf Wrist Wearables to Estimate Stress on Students
12:51

Evaluation of Commercial-Off-The-Shelf Wrist Wearables to Estimate Stress on Students

Published on: June 16, 2018

7.8K
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

893

Related Experiment Videos

Last Updated: Jan 10, 2026

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

7.2K
Evaluation of Commercial-Off-The-Shelf Wrist Wearables to Estimate Stress on Students
12:51

Evaluation of Commercial-Off-The-Shelf Wrist Wearables to Estimate Stress on Students

Published on: June 16, 2018

7.8K
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

893

Area of Science:

  • Neurology
  • Digital Health
  • Machine Learning

Background:

  • Myasthenia gravis (MG) presents with fluctuating muscle weakness and potential crises.
  • Limited access to care and fragmented data can delay critical interventions for MG patients.
  • Developing predictive algorithms for MG deterioration is crucial for timely management.

Purpose of the Study:

  • To develop predictive algorithms for myasthenia gravis (MG) deterioration.
  • To utilize multimodal telemedicine data, including patient-reported and wearable sensor data.
  • To enable earlier clinical interventions for worsening MG symptoms.

Main Methods:

  • A 12-week randomized controlled study involving 30 MG patients.
  • Utilized patient-reported outcome measures (PROMs) and patient-performed measures via a mobile app.
  • Collected data from wearables and trained a machine learning linear classifier to predict deterioration.

Main Results:

  • The predictive model achieved an AUROC of 0.85 using all input signals.
  • Performance remained stable across 4-10 day look-back windows.
  • PROMs indicated symptom worsening preceding deterioration; wearables alone showed higher predictive power.

Conclusions:

  • Multimodal self-monitoring via the MyaLink system effectively predicts MG deterioration.
  • The approach demonstrates good performance with acceptable false alarm rates.
  • This technology holds potential for earlier clinical intervention in myasthenia gravis.